Literature DB >> 31298704

Oxidative Stress in Response to Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.

Frank González1, Robert V Considine2, Ola A Abdelhadi3, Anthony J Acton2.   

Abstract

CONTEXT: Oxidative stress and insulin resistance are often present in polycystic ovary syndrome (PCOS).
OBJECTIVE: We determined the effect of saturated fat ingestion on leukocytic reactive oxygen species (ROS) generation, p47phox expression, and circulating thiobarbituric acid-reactive substances (TBARS) in women with PCOS.
DESIGN: Cross-sectional study.
SETTING: Academic medical center. PATIENTS: Twenty women of reproductive age with PCOS (10 lean, 10 with obesity) and 19 ovulatory control subjects (10 lean, 9 with obesity). MAIN OUTCOME MEASURES: ROS generation and p47phox mRNA and protein content were quantified in leukocytes, and TBARS was measured in plasma from blood drawn while the subjects were fasting and 2, 3, and 5 hours after saturated fat ingestion. Insulin sensitivity was derived from an oral glucose tolerance test (ISOGTT). Androgen secretion was assessed from blood drawn while the subjects were fasting and 24, 48, and 72 hours after human chorionic gonadotropin (HCG) administration.
RESULTS: Regardless of weight class, women with PCOS exhibited lipid-induced increases in leukocytic ROS generation and p47phox mRNA and protein content as well as plasma TBARS compared with lean control subjects. Both PCOS groups exhibited lower ISOGTT and greater HCG-stimulated androgen secretion compared with control subjects. The ROS generation, p47phox, and TBARS responses were negatively correlated with ISOGTT and positively correlated with HCG-stimulated androgen secretion.
CONCLUSION: In PCOS, increases in ROS generation, p47phox gene expression, and circulating TBARS in response to saturated fat ingestion are independent of obesity. Circulating mononuclear cells and excess adipose tissue are separate and distinct contributors to oxidative stress in this disorder.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31298704      PMCID: PMC6773460          DOI: 10.1210/jc.2019-00987

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  54 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

3.  Elevated plasma membrane cholesterol content alters macrophage signaling and function.

Authors:  Chunbo Qin; Tomokazu Nagao; Inna Grosheva; Frederick R Maxfield; Lynda M Pierini
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11-23       Impact factor: 8.311

4.  High efficiency of ROS production by glycerophosphate dehydrogenase in mammalian mitochondria.

Authors:  Tomás Mrácek; Alena Pecinová; Marek Vrbacký; Zdenek Drahota; Josef Houstek
Journal:  Arch Biochem Biophys       Date:  2008-10-12       Impact factor: 4.013

5.  Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.

Authors:  Frank González; Chang Ling Sia; Marguerite K Shepard; Neal S Rote; Judi Minium
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

Review 6.  Diacylglycerol--when is it an intracellular messenger?

Authors:  M J Wakelam
Journal:  Biochim Biophys Acta       Date:  1998-12-08

7.  TNFalpha release by the nonfat cells of human adipose tissue.

Authors:  J N Fain; S W Bahouth; A K Madan
Journal:  Int J Obes Relat Metab Disord       Date:  2004-04

8.  Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action.

Authors:  Vijayalakshmi Varma; Aiwei Yao-Borengasser; Neda Rasouli; Greg T Nolen; Bounleut Phanavanh; Tasha Starks; Cathy Gurley; Pippa Simpson; Robert E McGehee; Philip A Kern; Charlotte A Peterson
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-03-31       Impact factor: 4.310

9.  Saturated Fat Ingestion Promotes Lipopolysaccharide-Mediated Inflammation and Insulin Resistance in Polycystic Ovary Syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Anthony J Acton
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 5.958

Review 10.  Dyslipidemia in obesity: mechanisms and potential targets.

Authors:  Boudewijn Klop; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Nutrients       Date:  2013-04-12       Impact factor: 5.717

View more
  16 in total

1.  Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome.

Authors:  F González; R V Considine; O A Abdelhadi; A J Acton
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

2.  Association of Polymorphisms of Glutamate Cysteine Ligase Genes GCLC C-129 T and GCLM C-588 T with Risk of Polycystic Ovary Syndrome in Chinese Women.

Authors:  Chunyi Yang; Mingrong Xi; Hongwei Liu; Huai Bai; Chenyu Jiang; Qingqing Liu; Ping Fan
Journal:  Reprod Sci       Date:  2021-10-12       Impact factor: 3.060

3.  Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Jiaping Xue; Anthony J Acton
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-10-11       Impact factor: 4.310

4.  Association between CYP2E1 C-1054T and 96-bp I/D genetic variations and the risk of polycystic ovary syndrome in Chinese women.

Authors:  Y Pu; Q Liu; H Liu; H Bai; W Huang; M Xi; P Fan
Journal:  J Endocrinol Invest       Date:  2022-08-09       Impact factor: 5.467

5.  Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome.

Authors:  Yanyuan Zhou; Huan Lan; Zhewen Dong; Wanying Li; Bo Qian; Zhen Zeng; Wen He; Jia-Le Song
Journal:  Oxid Med Cell Longev       Date:  2022-05-26       Impact factor: 7.310

6.  Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Anthony J Acton
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

7.  Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome.

Authors:  Jiayu Huang; Jun Zhao; Xueying Geng; Weiwei Chu; Shang Li; Zi-Jiang Chen; Yanzhi Du
Journal:  Mol Ther Nucleic Acids       Date:  2020-12-15       Impact factor: 8.886

8.  16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome.

Authors:  Sitong Dong; Jiao Jiao; Shuangshuo Jia; Gaoyu Li; Wei Zhang; Kai Yang; Zhen Wang; Chao Liu; Da Li; Xiuxia Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-05-10       Impact factor: 5.293

9.  Integrated Analysis of miRNA-mRNA Interaction Network in Porcine Granulosa Cells Undergoing Oxidative Stress.

Authors:  Xing Du; Qiqi Li; Qiuyu Cao; Siqi Wang; Honglin Liu; Qifa Li
Journal:  Oxid Med Cell Longev       Date:  2019-11-04       Impact factor: 6.543

10.  Association of Prx4, Total Oxidant Status, and Inflammatory Factors with Insulin Resistance in Polycystic Ovary Syndrome.

Authors:  Sahar Mazloomi; Nasrin Sheikh; Marzieh Sanoee Farimani; Shamim Pilehvari
Journal:  Int J Endocrinol       Date:  2021-06-22       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.